"Als größtes Universitätsklinikum im Norden deckt das UKSH mit 92 Kliniken und Instituten in Kiel und Lübeck das gesamte Spektrum der modernen Medizin ab. 500.000 Patientinnen und Patienten profitieren jedes Jahr von der engen Verknüpfung der Spitzenmedizin des UKSH mit der innovativen Forschung der Universitäten in Kiel und Lübeck. Forschungsergebnisse gelangen hier direkt in die medizinische Praxis. Das Ergebnis ist ein exzellentes klinisches Niveau: Das UKSH ist Garant für höchst individualisierte sowie interdisziplinäre Diagnostik und Therapie. Dazu zählen medizinische Innovationen wie die Präzisionsmedizin für chronische Entzündungserkrankungen und Krebserkrankungen ebenso wie die digitalen Medien."

During the past decade, Universitätsklinikum Schleswig-Holstein Campus Lübeck-Kardiologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Schleswig-Holstein Campus Lübeck-Kardiologie" #1 collaborator was "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Schleswig-Holstein Campus Lübeck-Kardiologie" are "Heart Failure" (2 trials), "Cheyne Stokes Respiration" (1 trials), "Congestive Heart Failure" (1 trials), "Left Ventricular Systolic Dysfunction" (1 trials) and "Sleep Disorder" (1 trials). Many other conditions were trialed in "Universitätsklinikum Schleswig-Holstein Campus Lübeck-Kardiologie" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Schleswig-Holstein Campus Lübeck-Kardiologie" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Europe: AutoSet CS (USA: VPAP Adapt SV)" (1 trials) and "adaptive servoventilation (ASV)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Schleswig-Holstein Campus Lübeck-Kardiologie" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Schleswig-Holstein Campus Lübeck-Kardiologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Universitätsklinikum Schleswig-Holstein Campus Lübeck-Kardiologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Schleswig-Holstein Campus Lübeck-Kardiologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".